Jennifer Lopez Drops Bombshell: Cancels Tour Amid Divorce Rumors!

Jennifer Lopez has decided to cancel her summer tour of greatest hits to spend more time with her family, as reported by TMZ.

The 54-year-old singer was supposed to start the tour in late June, but she’s decided to stay home and be with her family and friends instead.

This news comes at a time when there are rumors about problems in her relationship with husband Ben Affleck.

PARIS, FRANCE – JULY 26: Jennifer Lopez and Ben Affleck are seen at the Louvre Museum on July 26, 2022 in Paris, France. (Photo by Pierre Suu/GC Images)

Lopez shared a message on her website to explain why she made the tough choice to cancel the tour.

“I am really sad and upset about disappointing you. Please understand that I wouldn’t do this if I didn’t feel like it was really important,” she wrote.

“I promise I’ll make it up to you, and we’ll all be together again. I love you all so much. Until next time…”

LOS ANGELES, CALIFORNIA – DECEMBER 05: Jennifer Lopez attends ELLE’s 2023 Women in Hollywood Celebration Presented by Ralph Lauren, Harry Winston and Viarae at Nya Studios on December 05, 2023 in Los Angeles, California. (Photo by Charley Gallay/Getty Images for ELLE )

Despite rumors suggesting poor ticket sales, a source told the DailyMail that wasn’t true and didn’t play a role in Lopez’s choice to cancel the tour.

“Jennifer made this tough decision this week, and she’s sorry to her fans,” the source said.

NEW YORK, NY – MARCH 30: Ben Affleck and Jennifer Lopez are seen leaving Sadelle’s restaurant on March 30, 2024 in New York, New York. (Photo by MEGA/GC Images)

Fans who bought tickets through Ticketmaster will get their money back automatically. But those who bought tickets through another company need to contact where they bought the tickets.

Wow! That’s a surprise!

We’ve All Waited for It: Scientists Created a Drug That Can Help Regrow Lost Teeth

The tooth fairy is a welcome guest for any child who has lost a tooth. Not only will the fairy leave a small gift under the child’s pillow, but they be assured of a replacement tooth in a few months. Unfortunately, the scenario is quite different for adults grappling with a loss of teeth. Luckily, there may be some hope thanks to a new study performed by scientists at Kyoto University and the University of Fukui.

A dental breakthrough

While the typical adult mouth houses 32 teeth, approximately 1% of the population exhibits variations of them, either possessing more or fewer teeth due to congenital conditions. Researchers have delved into the genetic factors behind cases of excessive teeth, seeking valuable insights into the potential regeneration of teeth in adults. This study is the first to show that monoclonal antibodies can help regrow teeth. It suggests a new way to treat a dental problem that currently requires implants and other artificial solutions.

A bit of science

The research team disclosed that an antibody targeting a specific gene, known as uterine sensitization-associated gene-1 (USAG-1), can induce tooth development in mice affected by tooth agenesis, a congenital condition. The findings were published in the journal, Science Advances.

As per Katsu Takahashi, a senior lecturer at the Kyoto University Graduate School of Medicine and one of the principal contributors to the study, the essential molecules crucial for the development of teeth have already been pinpointed. “The morphogenesis of individual teeth depends on the interactions of several molecules including BMP, or bone morphogenetic protein, and Wnt signaling,” says Takahashi.

On April 13, 2021, the University of Kyoto posted its first pic of newly-grown teeth in mice.

BMP and Wnt are involved in more than just tooth development; they affect the growth of organs and tissues early in the body’s development. Because drugs affecting them directly might have broad side effects, scientists are cautious. To find a potentially safer method, researchers focused on the gene USAG-1, thinking that aiming at factors countering BMP and Wnt specifically in tooth development could be more precise.

“We knew that suppressing USAG-1 benefits tooth growth. What we did not know was whether it would be enough,” added Takahashi.

The first results

Scientists looked at how different monoclonal antibodies affect USAG-1. Monoclonal antibodies are often used to treat things like cancer and arthritis and for making vaccines. Tests with this antibody showed that BMP signaling is crucial for deciding the number of teeth in mice. Also, just one treatment was enough to grow a whole tooth. Further tests confirmed these positive results in ferrets too.

“Ferrets are diphyodont animals with similar dental patterns to humans. Our next plan is to test the antibodies on other animals, such as pigs and dogs,” explained Takahashi.

Fully regrown frontal teeth in ferrets

The next steps

Now, scientists are going to test the drug on healthy adults. If that goes well, the team plans to try it on kids aged 2 to 6 with a rare tooth problem called anodontiaa genetic disorder defined as the absence of all teeth. These kids will get one shot of the drug to see if it makes their teeth grow. If everything works out, the medicine might be approved by 2030.

Takahashi sees the new medicine as an additional choice for individuals who are missing some or all of their teeth.

“The idea of growing new teeth is every dentist’s dream,” Takahashi told the Japanese newspaper, The Mainichi in June this year. “I’ve been working on this since I was a graduate student. I was confident I’d be able to make it happen.”

So hopefully, by the year 2030, humans will get a chance to have their third generation of teeth grown and say goodbye to implants. Until then, make sure to keep your teeth strong and healthy — this article will help you with that.

Preview photo credit KyotoU_News / Twitter

Related Posts

Be the first to comment

Leave a Reply

Your email address will not be published.


*